MESO Mesoblast Limited
$13.18▲ +6.38%
Healthcare
Other
After hours
$13.30▲ +0.91%
Oct 27, 4:01 PM ET
Volume 215.0K
Avg Volume (10D) 324.8K
Key Metrics & Fundamentals
Market Cap
$1.71B
P/E Ratio
–
Div Yield
0.00%
52W Range
11.89 - 21.50
% vs 50 MA
-12.54%
% vs 200 MA
-14.75%
RSI-14
44.6
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.53
Free Cash Flow
-$9.32M
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
Emerald Resources And 2 Australian Growth Stocks To Watch
Simply Wall St. · Oct 23, 2026 2:10 PM ET
3 Australian Founder Led Stocks With Revenue Up To A$2.9b
Simply Wall St. · Oct 22, 2026 6:14 PM ET
Cochlear Heads These 3 Top Australian Healthcare Stocks To Watch
Simply Wall St. · Oct 22, 2026 12:17 PM ET
3 Australian Growth Stocks With Revenue Growth Up To 38%
Simply Wall St. · Oct 20, 2026 12:11 PM ET
3 Australian Growth Stocks To Own In October 2026
Simply Wall St. · Oct 19, 2026 10:13 AM ET
These Australian Growth Stocks Stand Out In October 2026
Simply Wall St. · Oct 16, 2026 12:14 PM ET
3 Australian Healthcare Stocks To Watch In October 2026
Simply Wall St. · Oct 15, 2026 7:13 AM ET
3 Australian Growth Stocks With Up To 54% Earnings Growth
Simply Wall St. · Oct 9, 2026 9:12 AM ET
Top 3 Australian Healthcare Stocks To Watch In October 2026
Simply Wall St. · Oct 8, 2026 6:12 AM ET
Cochlear And 2 Australian Healthcare Stocks To Watch
Simply Wall St. · Sep 30, 2026 8:12 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See MESO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.